John Lim is a medical graduate of the National University of Singapore (NUS), and holds Masters degrees in Public Health from NUS and in Health Policy and Management from Harvard University. He is a Specialist in Public Health Medicine, a Fellow of the Singapore Academy of Medicine, and Adjunct Associate Professor at the NUS Saw Swee Hock School of Public Health and the Duke-NUS Graduate Medical School in Singapore.
In the course of his career, he has served as Administrator of the Singapore Blood Transfusion Service, Special Assistant to the Permanent Secretary for Health & Director of Medical Services, Deputy Medical Director of the Institute of Mental Health, and Director, Human Resource in Singapore’s Ministry of Health (MOH). He has also been Director of Higher Education and Director of Public Affairs in the Singapore Ministry of Education.
Following the establishment of the Health Sciences Authority (HSA), Dr Lim became Director of its Centre for Drug Administration in 2001. He was appointed HSA’s Chief Executive Officer in 2006 and led the organisation for eight years during a period of major development and growth. HSA has three key functions as Singapore’s regulator for health products, provider of expertise in forensic medicine, forensic science and analytical chemistry testing, and the national blood service for the country’s public and private hospitals.
In July 2014, Dr Lim assumed the concurrent appointments of Deputy Director of Medical Services (Industry & Research Matters) in MOH and Executive Director of the Centre of Regulatory Excellence (CoRE) at the Duke-NUS Graduate Medical School, Singapore. The MOH role is that of a deputy chief medical officer coordinating research initiatives and industry engagement. In CoRE, Dr Lim draws on his long-standing international experience and networks in health products regulation to enhance regulatory capacity and scientific excellence in the Asia-Pacific, and establish regional platforms to develop capabilities, enhance collaboration and promote thought leadership in regulatory science and policy.
Dr Lim is Chairman of the Singapore Clinical Research Institute, a national Academic Research Organisation under MOH Holdings, Singapore. He is a member of the Scientific Advisory Council of the UK-based Centre for Innovation in Regulatory Science, and a Board member of St Andrew’s Mission Hospital in Singapore. He has served on several other boards, including those of HSA, the National Healthcare Group, Singapore Polytechnic, and the Management Committee of the St Andrew’s Autism Centre.